Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now, it can notch one more black mark on its belt. The FDA ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, announced today the expansion of its Analytical Testing ...
To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused on Reliable Endotoxin Testing For Injectable Pharmaceuticals, a systematic ...
Doubts about product sterility have prompted Hospira to voluntarily recall a large quantity of injectable solutions, the US Food and Drug Administration (FDA) announced today. The injectables involved ...
Chicago, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The United States sterility testing market was valued at US$ 536.58 million in 2025 and is projected to hit the valuation of US$ 1,599.34 million by 2035 at ...
The FDA has posted the warning letter that Teva recently acknowledged getting for its troubled sterile manufacturing plant in Hungary. The letter outlines concerns about sterility and contamination ...
The recalled lots of Levetiracetam Injection 500mg per 5mL; NDC Number 25021-780-05, were distributed nationwide from March to November 2021. Sagent Pharmaceuticals, Inc. is voluntarily recalling 4 ...
Dublin, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The "U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (Outsourcing, In-house), By Product, By Test (Sterility Testing ...
(MENAFN- GlobeNewsWire - Nasdaq) This report, published by Towards Healthcare, a sister firm of Precedence Research, provides a comprehensive analysis of the sterile drug product testing market, ...
DUBLIN--(BUSINESS WIRE)--The "Global Sterility Testing Market, 2017 to 2025" report has been added to Research and Markets' offering. The global Sterility Testing market was valued at US$ 548.2 Mn in ...
As the demand for biologics accelerates, biopharma companies are under pressure to expand sterile manufacturing capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results